Design, synthesis and apoptotic effects of novel benzoxazole compounds

Z Naturforsch C J Biosci. 2023 Nov 1;78(11-12):433-440. doi: 10.1515/znc-2023-0099. Print 2023 Nov 27.

Abstract

A series of new benzoxazole-hydrazone and benzoxazole-1,3,4-oxadiazole derivatives have been designed, synthesized and evaluated as cytotoxic agents toward human A549 lung cancer cells. Compounds 3d, 3e, 5b, 5c, 5d and 5e were the most potent compounds with IC50 values of <3.9, 10.33, 11.6, 5.00, <3.9 and 4.5 μg/mL, respectively, which are higher than reference drug cisplatin (IC50 = 19.00 μg/mL). The flow cytometry-based apoptosis detection assay was performed to determine their effects on apoptosis in A549 cells. All tested compounds induced apoptosis in A549 cell line.

Keywords: 1,3,4-oxadiazole; MTT; benzoxazole; hydrazone; lung cancer.

MeSH terms

  • A549 Cells
  • Antineoplastic Agents*
  • Apoptosis
  • Benzoxazoles / pharmacology
  • Benzoxazoles / therapeutic use
  • Cell Line, Tumor
  • Cell Proliferation
  • Cisplatin / pharmacology
  • Drug Screening Assays, Antitumor
  • Humans
  • Lung Neoplasms* / drug therapy
  • Lung Neoplasms* / metabolism
  • Molecular Structure
  • Structure-Activity Relationship

Substances

  • Antineoplastic Agents
  • Benzoxazoles
  • Cisplatin